Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q3MHR2

Entry ID Method Resolution Chain Position Source
AF-Q3MHR2-F1 Predicted AlphaFoldDB

102 variants for Q3MHR2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs479077247 7 R>W No EVA
rs457716991 8 S>R No EVA
rs439197141 8 S>R No EVA
rs482833861 17 E>G No EVA
rs449754041 19 T>P No EVA
rs454905435 72 T>P No EVA
rs473519995 73 T>S No EVA
rs452481587 75 Q>E No EVA
rs471211086 77 S>R No EVA
rs444566767 78 G>C No EVA
rs134192854 80 N>D No EVA
rs459973977 80 N>K No EVA
rs441596809 80 N>S No EVA
rs445732242 81 V>D No EVA
rs478787872 81 V>F No EVA
rs445732242 81 V>G No EVA
rs457718254 82 L>F No EVA
rs457718254 82 L>I No EVA
rs457718254 82 L>V No EVA
rs449867298 83 Q>H No EVA
rs482890680 83 Q>L No EVA
rs482890680 83 Q>P No EVA
rs482890680 83 Q>R No EVA
rs448541126 84 M>I No EVA
rs435455348 84 M>K No EVA
rs468502648 84 M>L No EVA
rs468502648 84 M>V No EVA
rs452602956 85 M>I No EVA
rs433928152 85 M>K No EVA
rs467002064 85 M>L No EVA
rs433928152 85 M>T No EVA
rs467002064 85 M>V No EVA
rs456551989 86 Y>* No EVA
rs438194480 86 Y>C No EVA
rs471040879 86 Y>D No EVA
rs438194480 86 Y>F No EVA
rs475155123 87 E>* No EVA
rs460639004 87 E>D No EVA
rs442266576 87 E>G No EVA
rs475155123 87 E>K No EVA
rs442266576 87 E>V No EVA
rs472232903 88 K>E No EVA
rs439156664 88 K>I No EVA
rs457855684 88 K>N No EVA
rs472232903 88 K>Q No EVA
rs482768781 89 P>A No EVA
rs449930819 89 P>H No EVA
rs482768781 89 P>T No EVA
rs480374931 90 E>* No EVA
rs480374931 90 E>K No EVA
rs480374931 90 E>Q No EVA
rs447588112 90 E>V No EVA
rs433990436 91 R>P No EVA
rs464694937 92 W>G No EVA
rs438055538 92 W>L No EVA
rs464694937 92 W>R No EVA
rs456615445 93 S>A No EVA
rs468612660 93 S>C No EVA
rs468612660 93 S>F No EVA
rs468612660 93 S>Y No EVA
rs454432304 94 F>Y No EVA
rs439218983 95 T>I No EVA
rs439218983 95 T>N No EVA
rs472841071 95 T>P No EVA
rs472841071 95 T>S No EVA
rs480436703 97 Q>H No EVA
rs443332972 97 Q>K No EVA
rs461794961 97 Q>L No EVA
rs461794961 97 Q>P No EVA
rs441011025 98 S>T No EVA
rs446074123 100 A>G No EVA
rs478133662 100 A>S No EVA
rs482785739 101 C>F No EVA
rs464515737 101 C>R No EVA
rs482785739 101 C>S No EVA
rs450097045 102 L>P No EVA
rs435767295 103 S>R No EVA
rs454228143 103 S>T No EVA
rs466510289 106 R>Q No EVA
rs451321314 108 Q>H No EVA
rs455446066 123 V>A No EVA
rs441019996 124 L>* No EVA
rs459475959 126 F>Y No EVA
rs478189650 131 Y>H No EVA
rs438698296 132 S>R No EVA
rs463617157 133 D>E No EVA
rs443069155 137 F>L No EVA
rs443069155 137 F>V No EVA
rs473742383 146 C>S No EVA
rs459133766 152 W>C No EVA
rs476826917 154 I>M No EVA
rs450382754 161 W>L No EVA
rs448226422 173 D>E No EVA
rs445949829 176 I>F No EVA
rs464424856 176 I>M No EVA
rs432378526 179 R>G No EVA
rs479067927 223 T>S No EVA
rs450233975 247 D>N No EVA
rs464085145 258 S>G No EVA
rs482569996 260 L>W No EVA
rs467403260 261 L>C No EVA
rs448826930 261 L>S No EVA

No associated diseases with Q3MHR2

1 regional properties for Q3MHR2

Type Name Position InterPro Accession
domain Deoxynucleoside kinase domain 23 - 257 IPR031314

Functions

Description
EC Number 2.7.1.74 Phosphotransferases with an alcohol group as acceptor
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

7 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
cytidine kinase activity Catalysis of the reaction: ATP + cytidine = ADP + CMP.
deoxyadenosine kinase activity Catalysis of the reaction: 2'-deoxyadenosine + ATP = ADP + dAMP + 2 H(+).
deoxycytidine kinase activity Catalysis of the reaction: NTP + deoxycytidine = NDP + CMP.
deoxyguanosine kinase activity Catalysis of the reaction: 2'-deoxyguanosine + ATP = ADP + dGMP + 2 H(+).
deoxynucleoside kinase activity Catalysis of the reaction: ATP + 2'-deoxynucleoside = ADP + 2'-deoxynucleoside 5'-phosphate.
protein homodimerization activity Binding to an identical protein to form a homodimer.

3 GO annotations of biological process

Name Definition
dAMP salvage Any process which produces a dAMP from derivatives of it, without de novo synthesis.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
pyrimidine nucleotide metabolic process The chemical reactions and pathways involving a pyrimidine nucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O00142 TK2 Thymidine kinase 2, mitochondrial Homo sapiens (Human) PR
P43346 Dck Deoxycytidine kinase Mus musculus (Mouse) PR
10 20 30 40 50 60
MATPPKRSCP SPAASSEGTR IKKISIEGNI AAGKSTFVNI LKQVCEDWEV VPEPVARWCN
70 80 90 100 110 120
VQSTQDEFEE LTTSQKSGGN VLQMMYEKPE RWSFTFQSYA CLSRIRAQLA ALNGKLKDAE
130 140 150 160 170 180
KPVLFFERSV YSDRYIFASN LYESDCMNET EWTIYQDWHD WMNNQFGQSL ELDGIIYLRA
190 200 210 220 230 240
TPEKCLNRIY LRGRNEEQGI PLEYLEKLHY KHESWLLHRT LKTNFDYLQE VPILTLDVNE
250
DFKDKHDSLI EKVKDFLSTL